Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (395) 395
life sciences & biomedicine (368) 368
humans (341) 341
female (241) 241
male (240) 240
middle aged (220) 220
urology & nephrology (183) 183
adult (180) 180
risk factors (154) 154
aged (142) 142
umcg approved (118) 118
biological and medical sciences (98) 98
medical sciences (96) 96
glomerular filtration rate (94) 94
mortality (93) 93
glomerular-filtration-rate (88) 88
albuminuria (85) 85
hypertension (77) 77
nephrology (74) 74
prospective studies (74) 74
population (68) 68
chronic kidney disease (67) 67
risk (64) 64
epidemiology (63) 63
cardiovascular system & cardiology (61) 61
transplantation (60) 60
cardiovascular disease (58) 58
kidney diseases (57) 57
disease progression (55) 55
prognosis (53) 53
cohort studies (52) 52
nephrology. urinary tract diseases (52) 52
medicin och hälsovetenskap (47) 47
microalbuminuria (47) 47
blood pressure (46) 46
chronic kidney-disease (45) 45
diabetes (45) 45
abridged index medicus (44) 44
follow-up studies (44) 44
disease (43) 43
research (42) 42
cardiovascular diseases (41) 41
incidence (41) 41
proteinuria (41) 41
urologic and male genital diseases (39) 39
general & internal medicine (38) 38
adpkd (37) 37
medicine, general & internal (37) 37
cardiac & cardiovascular systems (36) 36
kidneys (36) 36
biomarkers (35) 35
biomarkers - blood (35) 35
blood-pressure (35) 35
risk assessment (35) 35
peripheral vascular disease (33) 33
polycystic kidney disease (33) 33
time factors (33) 33
albuminuria - diagnosis (32) 32
albuminuria - urine (32) 32
netherlands - epidemiology (32) 32
progression (32) 32
urinary albumin excretion (32) 32
vasopressin (32) 32
cardiovascular events (31) 31
medicine (31) 31
studies (31) 31
analysis (30) 30
chronic kidney failure (30) 30
end-stage renal disease (30) 30
predictive value of tests (29) 29
autosomal dominant polycystic kidney disease (28) 28
body mass index (28) 28
cross-sectional studies (28) 28
biomarkers - urine (27) 27
general-population (27) 27
heart failure (27) 27
multidisciplinary sciences (27) 27
science & technology - other topics (27) 27
cardiology. vascular system (26) 26
prevalence (26) 26
proportional hazards models (26) 26
aged, 80 and over (25) 25
cardiovascular-disease (25) 25
stage renal-disease (25) 25
urine (25) 25
coronary-heart-disease (24) 24
polycystic kidney, autosomal dominant - physiopathology (24) 24
renal-disease (24) 24
young adult (24) 24
c-reactive protein (23) 23
creatinine - urine (23) 23
endocrinology & metabolism (23) 23
longitudinal studies (23) 23
medical and health sciences (23) 23
meta-analysis (23) 23
metaanalysis (23) 23
nephropathies. renovascular diseases. renal failure (23) 23
polycystic kidney, autosomal dominant - drug therapy (23) 23
urinary system involvement in other diseases. miscellaneous (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
by Gansevoort, Ron T, Dr and Correa-Rotter, Ricardo, Prof and Hemmelgarn, Brenda R, Prof and Jafar, Tazeen H, Prof and Heerspink, Hiddo J Lambers, PharmSc and Mann, Johannes F, Prof and Matsushita, Kunihiro, MD and Wen, Chi Pang, Prof
The Lancet (British edition), ISSN 0140-6736, 07/2013, Volume 382, Issue 9889, pp. 339 - 352
Internal Medicine | ALL-CAUSE MORTALITY | GLOMERULAR-FILTRATION-RATE | COMMUNITY-BASED POPULATION | BLOOD-PRESSURE CONTROL | RANDOMIZED CONTROLLED-TRIAL | VITAMIN-D THERAPY | ACUTE CORONARY SYNDROME | STAGE RENAL-DISEASE | ELEVATION MYOCARDIAL-INFARCTION | LEFT-VENTRICULAR HYPERTROPHY | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Kidneys | Urinary system involvement in other diseases. Miscellaneous | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Epidemiology | Albuminuria - complications | Cardiovascular Diseases - etiology | Glomerular Filtration Rate | Life Expectancy | Cardiovascular Diseases - prevention & control | Humans | Risk Factors | Cardiovascular Diseases - epidemiology | Cost of Illness | Female | Male | Renal Insufficiency, Chronic - complications | Prevention | Complications and side effects | Chronic kidney failure | Heart diseases | Risk factors | Hypertension | Cardiovascular disease | Diabetes | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Albuminuria as a cause of hypertension
by Gansevoort, Ron T and Snieder, Harold
Nature reviews. Nephrology, ISSN 1759-5061, 01/2019, Volume 15, Issue 1, pp. 6 - 8
ASSOCIATION | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Hypertension | Analysis | Risk assessment | Genetic aspects | Albuminuria | Research | Cardiovascular diseases | Risk factors | Prevalence studies (Epidemiology) | Sodium | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Effect of finerenone on albuminuria in patients with diabetic nephropathy a randomized clinical trial
by Bakris, George L and Agarwal, Rajiv and Chan, Juliana C and Cooper, Mark E and Gansevoort, Ron T and Haller, Hermann and Remuzzi, Giuseppe and Rossing, Peter and Schmieder, Roland E and Nowack, Christina and Kolkhof, Peter and Joseph, Amer and Pieper, Alexander and Kimmeskamp-Kirschbaum, Nina and Ruilope, Luis M and Mineralocorticoid Receptor and Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2015, Volume 314, Issue 9, pp. 884 - 894
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Naphthyridines - adverse effects | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Incidence | Dose-Response Relationship, Drug | Diabetes Mellitus, Type 2 - ethnology | Glomerular Filtration Rate - drug effects | Diabetic Nephropathies - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hyperkalemia - epidemiology | Female | Blood Pressure - drug effects | Diabetes Mellitus, Type 2 - complications | Diabetic Nephropathies - urine | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Diabetes Mellitus, Type 2 - urine | Diabetic Nephropathies - ethnology | Creatinine - urine | Mineralocorticoid Receptor Antagonists - therapeutic use | Analysis of Variance | Albuminuria - drug therapy | Hyperkalemia - chemically induced | Least-Squares Analysis | Potassium - blood | Aged | Angiotensin Receptor Antagonists - therapeutic use | Naphthyridines - administration & dosage | Proteins | Clinical trials | Side effects | Diabetes | Antagonist drugs | ACE inhibitors
Journal Article
Details down arrow
4. Full Text Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
by Torres, Vicente E and Chapman, Arlene B and Devuyst, Olivier and Gansevoort, Ron T and Grantham, Jared J and Higashihara, Eiji and Perrone, Ronald D and Krasa, Holly B and Ouyang, John and Czerwiec, Frank S and TEMPO 3 4 Trial Investigators
The New England journal of medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 25, pp. 2407 - 2418
VOLUME PROGRESSION | VASOPRESSIN V-2-RECEPTOR ANTAGONIST | ORAL TOLVAPTAN | HYPONATREMIA | RENAL-FUNCTION | OPC-41061 | LONG-ACTING SOMATOSTATIN | V2 RECEPTOR ANTAGONIST | UMCG Approved | CYST GROWTH | SIROLIMUS | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Nephrology. Urinary tract diseases | Biological and medical sciences | General aspects | Kidneys | Medical sciences | Malformations of the urinary system | Drugs | Dose-response relationship (Biochemistry) | Product/Service Evaluations | Drug therapy | Polycystic kidney disease | Studies | Nuclear magnetic resonance--NMR | Kidney diseases | Cysts | Rodents | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
by Torres, Vicente E and Chapman, Arlene B and Devuyst, Olivier and Gansevoort, Ron T and Perrone, Ronald D and Koch, Gary and Ouyang, John and McQuade, Robert D and Blais, Jaime D and Czerwiec, Frank S and Sergeyeva, Olga and REPRISE Trial Investigators
The New England journal of medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 20, pp. 1930 - 1942
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Polycystic Kidney, Autosomal Dominant - blood | Benzazepines - adverse effects | Humans | Middle Aged | Male | Alanine Transaminase - blood | Antidiuretic Hormone Receptor Antagonists - therapeutic use | Antidiuretic Hormone Receptor Antagonists - adverse effects | Young Adult | Bilirubin - blood | Glomerular Filtration Rate - drug effects | Tolvaptan | Kidney Failure, Chronic - prevention & control | Benzazepines - therapeutic use | Adolescent | Adult | Female | Aged | Polycystic Kidney, Autosomal Dominant - physiopathology | Polycystic Kidney, Autosomal Dominant - drug therapy | Treatment outcome | Drug therapy | Patient outcomes | Analysis | Polycystic kidney disease | Hypertension | Creatinine | Alanine | Nephrology | Polycystic kidney | Bilirubin | Patients | Vasopressin | Glomerular filtration rate | Cysts | Alanine transaminase | Kidney diseases | Drug dosages | Age | Pharmaceuticals | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
by Levey, Andrew S and de Jong, Paul E and Coresh, Josef and Nahas, Meguid E.l and Astor, Brad C and Matsushita, Kunihiro and Gansevoort, Ron T and Kasiske, Bertram L and Eckardt, Kai-Uwe
Kidney international, ISSN 0085-2538, 07/2011, Volume 80, Issue 1, pp. 17 - 28
albuminuria | chronic kidney disease | definition | classification | glomerular filtration rate | prognosis | UNITED-STATES | PROTEINURIA | ADVERSE OUTCOMES | RENAL-DISEASE | UMCG Approved | GLOMERULAR-FILTRATION-RATE | URINARY ALBUMIN EXCRETION | ALL-CAUSE | RISK-FACTOR | CARDIOVASCULAR-DISEASE | ASSOCIATION | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Kidneys | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Kidney Failure, Chronic - physiopathology | Meta-Analysis as Topic | Glomerular Filtration Rate | Kidney Failure, Chronic - diagnosis | Prognosis | Renal Insufficiency, Chronic - classification | United States | Humans | Renal Insufficiency, Chronic - physiopathology | Albuminuria - physiopathology | Societies, Medical | Kidney Failure, Chronic - classification | Renal Insufficiency, Chronic - diagnosis | Practice Guidelines as Topic | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text CKD is a key risk factor for COVID-19 mortality
by Gansevoort, Ron T and Hilbrands, Luuk B
Nature reviews. Nephrology, ISSN 1759-5061, 08/2020, Volume 16, Issue 12, pp. 705 - 706
Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | COVID-19 | Renal Insufficiency, Chronic - epidemiology | SARS-CoV-2 | Pandemics | Humans | Risk Factors | Evaluation | Complications and side effects | Forecasts and trends | Kidney diseases | Health risk assessment | Mortality | Coronaviruses | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Cystatin C versus Creatinine in Determining Risk Based on Kidney Function
by Shlipak, Michael G and Matsushita, Kunihiro and Ärnlöv, Johan and Inker, Lesley A and Katz, Ronit and Polkinghorne, Kevan R and Rothenbacher, Dietrich and Sarnak, Mark J and Astor, Brad C and Coresh, Josef and Levey, Andrew S and Gansevoort, Ron T and CKD Prognosis Consortium
The New England journal of medicine, ISSN 0028-4793, 09/2013, Volume 369, Issue 10, pp. 932 - 943
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Renal Insufficiency, Chronic - blood | Risk Assessment - methods | Reference Standards | Glomerular Filtration Rate | Cystatin C - blood | Humans | Creatinine - blood | Renal Insufficiency, Chronic - mortality | Risk | Renal Insufficiency, Chronic - physiopathology | Kidney Failure, Chronic - etiology | Kidney Function Tests | Kidney diseases | Diagnosis | Research | Biological markers | Comparative analysis | Creatinine | Cystatin | End-stage renal disease | Heart attacks | Kidneys | Epidermal growth factor receptors | Medical treatment | Population studies | Epidemiology | Reclassification | Glomerular filtration rate | Medical prognosis | Cystatin C | Population | Death | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality
by Coresh, Josef and Turin, Tanvir Chowdhury and Matsushita, Kunihiro and Sang, Yingying and Ballew, Shoshana H and Appel, Lawrence J and Arima, Hisatomi and Chadban, Steven J and Cirillo, Massimo and Djurdjev, Ognjenka and Green, Jamie A and Heine, Gunnar H and Inker, Lesley A and Irie, Fujiko and Ishani, Areef and Ix, Joachim H and Kovesdy, Csaba P and Marks, Angharad and Ohkubo, Takayoshi and Shalev, Varda and Shankar, Anoop and Wen, Chi Pang and De Jong, Paul E and Iseki, Kunitoshi and Stengel, Benedicte and Gansevoort, Ron T and Levey, Andrew S and CKD Prognosis Consortium
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 2014, Volume 311, Issue 24, pp. 2518 - 2531
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Kidney Failure, Chronic - mortality | Kidney Failure, Chronic - physiopathology | Glomerular Filtration Rate | Humans | Middle Aged | Male | Reference Values | Risk | Disease Progression | Endpoint Determination | Aged, 80 and over | Creatinine - blood | Adult | Female | Aged | Cohort Studies | Nephrology | Kidney diseases | Mortality | Clinical outcomes
Journal Article
Details down arrow